The FAA Recognizes the Value of GeneLink's DNA Storage System
June 2, 1999

MARGATE, NJ, -(Business Wire)-June 2, 1999 - GeneLink BioSciences, Inc. (OTC BB: GNLK-news) announces the recognition of it's proprietary DNA Storage System by the Federal Aviation Administration. As technological advances in genetic science have made DNA a worldwide standard for identity verification, many experts within the FAA and Department of Transportation recommend that individuals, especially frequent travelers, store samples of their own DNA for emergency identification purposes. As an innovator in confidential and guaranteed DNA "banking", GeneLink offers the public an inexpensive resource.

GeneLink offers its services directly to the public at www.genelink.info. 

Dennis Canfield, PhD, and Ronald Hansrote, MD recently published an article in the Federal Air Surgeon's Medical Bulletin that discusses the benefits of DNA banking for identification purposes. Dr. Canfield and Dr. Hansrote are managers with the FAA's Civil Aeromedical Institute. According to Dr.'s Canfield and Hansrote, "To identify individuals by DNA analysis, one must have a reference DNA sample This reference sample could be DNA collected from the individual prior to an accident or DNA specimens collected from immediate family members such as biological mother, father, siblings, and children." 

"However, collecting reference samples from family members after a fatal accident is difficult „ For a small fee, commercial DNA storage is now available for individuals to "bank" their DNA for later use in personal identification. Certified laboratories (e.g. GeneLink) can store DNA samples for up to 20 years. DNA sample collection kits are available, are simple to use, are non-invasive, and the DNA can be collected without medical assistance. Insurance companies will sometimes pay for storing DNA samples."

Forward-Looking Statements: This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a new "safe harbor" for these types of statements. 

SOURCE: GeneLink BioSciences, Inc.